Google Übersetzer
Atyr Pharma, Inc.
About
Atyr Pharma, Inc. (NASDAQ:ATYR) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 5 2026
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
Feb 3 2026
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
Nov 10 2025
aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference
Nov 6 2025
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update
Nov 6 2025
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update
Financials
Revenue
$190 K
Market Cap
$83.04 M
EPS
-0.80